Company Filing History:
Years Active: 2016-2018
Title: Muriel Lemaire: Innovator in Antibody Production
Introduction
Muriel Lemaire is a notable inventor based in Ottignies, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of methods for producing antibodies. With a total of 2 patents, her work has the potential to impact various applications in medical research and therapeutics.
Latest Patents
Lemaire's latest patents focus on a method for producing antibodies using a 'naked' expression vector that expresses a type II transmembrane fusion protein. The disclosed methods involve generating antibodies and utilizing an expression vector to express proteins that provoke an antibody response. This expression vector is designed to generate antibodies directed to an antigen, comprising a gene in operable linkage with a promoter. The gene encodes a fusion protein that includes CD134L as the N-terminal moiety and an antigenic protein as the C-terminal moiety. The process involves injecting the vector into a subject animal, which subsequently produces a fusion protein, leading to the generation of antibodies.
Career Highlights
Muriel Lemaire is currently associated with Delphi Genetics S.A., where she continues to advance her research in antibody production. Her innovative approaches have garnered attention in the scientific community, contributing to the understanding of antibody generation.
Collaborations
Lemaire has collaborated with notable colleagues, including Jean-Christophe Renauld and Laurie Dumoutier, who have supported her research endeavors.
Conclusion
Muriel Lemaire's work in antibody production exemplifies the innovative spirit of modern biotechnology. Her contributions through her patents and collaborations highlight the importance of research in developing new therapeutic methods.